Therapeutics investor at inaugural TCG Labs Fund I. TCG Labs-Soleil is a new venture model from The Column Group that blends investors and R&D operations under one roof with a focus on products rather than platforms, and M&A rather than IPO. Our goal is to develop therapies to human proof-of-concept as efficiently as possible.

Venture capital investor in biotech and healthtech, with a specialty in therapeutics and precision medicine

Drug hunter role encompassing finding, licensing, and spinning-out assets into new companies, including BD & operational roles. Served on two boards for subsidiary companies and led four investments.

Head of business development, investor relations, and research strategy.

Corporate development (strategic partnering, M&A, reverse merger, licensing), fundraising (financial analysis, seed/series A/series B capital sourcing), and scientific strategy (preclinical, clinical).

Due diligence into commercialization of life science technologies

Molecular Biology, In Vivo Mouse Model, Lab Manager